Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.2 EUR
−12.04 M EUR
1.80 B EUR
13.07 M
About REDCARE PHARMACY N.V.
Sector
Industry
CEO
Olaf Heinrich
Website
Headquarters
Sevenum
Founded
2021
ISIN
NL0012044747
FIGI
BBG00DSX0K94
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RDC is 137.5 EUR — it has increased by 0.95% in the past 24 hours. Watch REDCARE PHARMACY N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange REDCARE PHARMACY N.V. stocks are traded under the ticker RDC.
RDC stock has fallen by −5.95% compared to the previous week, the month change is a −4.11% fall, over the last year REDCARE PHARMACY N.V. has showed a 5.40% increase.
We've gathered analysts' opinions on REDCARE PHARMACY N.V. future price: according to them, RDC price has a max estimate of 202.00 EUR and a min estimate of 85.00 EUR. Watch RDC chart and read a more detailed REDCARE PHARMACY N.V. stock forecast: see what analysts think of REDCARE PHARMACY N.V. and suggest that you do with its stocks.
RDC stock is 4.08% volatile and has beta coefficient of 1.01. Track REDCARE PHARMACY N.V. stock price on the chart and check out the list of the most volatile stocks — is REDCARE PHARMACY N.V. there?
Today REDCARE PHARMACY N.V. has the market capitalization of 2.75 B, it has decreased by −8.22% over the last week.
Yes, you can track REDCARE PHARMACY N.V. financials in yearly and quarterly reports right on TradingView.
REDCARE PHARMACY N.V. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
RDC earnings for the last quarter are −0.41 EUR per share, whereas the estimation was −0.41 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.92 EUR per share. See more details about REDCARE PHARMACY N.V. earnings.
REDCARE PHARMACY N.V. revenue for the last quarter amounts to 574.55 M EUR, despite the estimated figure of 574.40 M EUR. In the next quarter, revenue is expected to reach 684.13 M EUR.
RDC net income for the last quarter is −6.91 M EUR, while the quarter before that showed −4.27 M EUR of net income which accounts for −62.03% change. Track more REDCARE PHARMACY N.V. financial stats to get the full picture.
No, RDC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 2.08 K employees. See our rating of the largest employees — is REDCARE PHARMACY N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REDCARE PHARMACY N.V. EBITDA is 29.62 M EUR, and current EBITDA margin is 2.25%. See more stats in REDCARE PHARMACY N.V. financial statements.
Like other stocks, RDC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REDCARE PHARMACY N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REDCARE PHARMACY N.V. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REDCARE PHARMACY N.V. stock shows the buy signal. See more of REDCARE PHARMACY N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.